Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Author: Benzinga Insights | May 23, 2023 09:06am

Gainers

  • CohBar (NASDAQ:CWBR) stock rose 192.9% to $4.54 during Tuesday's pre-market session. The market value of their outstanding shares is at $13.1 million.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) shares rose 50.48% to $1.55. The market value of their outstanding shares is at $21.1 million.
  • Biocept (NASDAQ:BIOC) shares increased by 36.43% to $6.74. The market value of their outstanding shares is at $3.9 million.
  • Finch Therapeutics Gr (NASDAQ:FNCH) shares rose 14.39% to $0.33. The market value of their outstanding shares is at $15.7 million.
  • Icosavax (NASDAQ:ICVX) shares moved upwards by 14.23% to $8.99. The market value of their outstanding shares is at $372.4 million.
  • IMAC Hldgs (NASDAQ:BACK) shares moved upwards by 12.83% to $0.16. The company's market cap stands at $5.2 million. As per the press release, Q1 earnings came out 2 days ago.

Losers

  • Oncorus (NASDAQ:ONCR) shares fell 33.3% to $0.21 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.4 million. As per the press release, Q1 earnings came out yesterday.
  • NantHealth (NASDAQ:NH) shares declined by 23.32% to $1.94. The company's market cap stands at $14.9 million.
  • WAVE Life Sciences (NASDAQ:WVE) stock declined by 15.1% to $3.15. The company's market cap stands at $309.8 million.
  • Integra Lifesciences (NASDAQ:IART) shares fell 14.1% to $43.57. The market value of their outstanding shares is at $3.5 billion.
  • Bluejay Diagnostics (NASDAQ:BJDX) shares decreased by 11.89% to $0.2. The market value of their outstanding shares is at $4.1 million.
  • Aridis Pharmaceuticals (NASDAQ:ARDS) stock fell 11.68% to $0.19. The market value of their outstanding shares is at $7.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ARDS BACK BIOC BJDX CWBR FNCH IART ICVX NH ONCR SHPH WVE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist